Focused Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-647
| Closed | -$24K | – | 505 |
|
|
2023
Q4 | $24K | Sell |
647
-27,196
| -98% | -$976K | ﹤0.01% | 420 |
|
|
2023
Q3 | $1.01M | Buy |
27,843
+444
| +2% | +$15.8K | 0.18% | 53 |
|
|
2023
Q2 | $976K | Buy |
27,399
+807
| +3% | +$28.9K | 0.18% | 54 |
|
|
2023
Q1 | $946K | Buy |
26,592
+460
| +2% | +$16.1K | 0.19% | 52 |
|
|
2022
Q4 | $918K | Buy |
26,132
+54
| +0.2% | +$1.8K | 0.19% | 60 |
|
|
2022
Q3 | $767K | Buy |
26,078
+26,070
| +325,875% | +$988K | 0.16% | 61 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 983 |
|
|
2022
Q1 | $0 | Sell |
8
-1,600
| -100% | -$86.9K | ﹤0.01% | 1031 |
|
|
2021
Q4 | $89K | Buy |
1,608
+1,597
| +14,518% | +$83.1K | 0.01% | 291 |
|
|
2021
Q3 | $1K | Buy |
11
+3
| +38% | +$151 | ﹤0.01% | 892 |
|
|
2021
Q2 | $0 | Buy |
+8
| New | +$384 | ﹤0.01% | 971 |
|
|
2018
Q2 | – | Sell |
-240
| Closed | -$12K | – | 697 |
|
|
2018
Q1 | $12K | Sell |
240
-566
| -70% | -$26.4K | ﹤0.01% | 451 |
|
|
2017
Q4 | $36K | Hold |
806
| – | – | 0.01% | 330 |
|
|
2017
Q3 | $41K | Buy |
806
+240
| +42% | +$12.2K | 0.01% | 257 |
|
|
2017
Q2 | $30K | Buy |
566
+8
| +1% | +$426 | 0.01% | 336 |
|
|
2017
Q1 | $29K | Sell |
558
-74
| -12% | -$3.75K | 0.01% | 337 |
|
|
2016
Q4 | $30K | Buy |
632
+6
| +1% | +$296 | 0.01% | 329 |
|
|
2016
Q3 | $34K | Buy |
626
+6
| +1% | +$329 | 0.01% | 308 |
|
|
2016
Q2 | $34K | Sell |
620
-390
| -39% | -$20.5K | 0.02% | 294 |
|
|
2016
Q1 | $51K | Sell |
1,010
-1,018
| -50% | -$50.7K | 0.03% | 191 |
|
|
2015
Q4 | $102K | Buy |
2,028
+87
| +4% | +$4.43K | 0.06% | 151 |
|
|
2015
Q3 | $93K | Buy |
1,941
+7
| +0.4% | +$364 | 0.06% | 145 |
|
|
2015
Q2 | $101K | Buy |
1,934
+398
| +26% | +$22.4K | 0.06% | 137 |
|
|
2015
Q1 | $89K | Buy |
1,536
+7
| +0.5% | +$401 | 0.05% | 149 |
|
|
2014
Q4 | $82K | Buy |
1,529
+7
| +0.5% | +$392 | 0.06% | 150 |
|
|
2014
Q3 | $87K | Sell |
1,522
-195
| -11% | -$12K | 0.07% | 149 |
|
|
2014
Q2 | $115K | Buy |
1,717
+34
| +2% | +$2.3K | 0.09% | 119 |
|
|
2014
Q1 | $112K | Buy |
1,683
+5
| +0.3% | +$338 | 0.09% | 118 |
|
|
2013
Q4 | $112K | Buy |
1,678
+5
| +0.3% | +$324 | 0.09% | 121 |
|
|
2013
Q3 | $105K | Buy |
+1,673
| New | +$108K | 0.1% | 120 |
|
Other funds holding GSK
JEST
Focused Wealth Management's GSK Position: Q1 2024 in Review
Focused Wealth Management sold out of GSK (GSK) in Q1 2024, closing a stake of 647 shares — an estimated $24K sold.
Focused Wealth Management first reported a position in GSK in Q3 2013 and held it in 30 quarters. The position peaked at $1.01M in Q3 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.
- Focused Wealth Management reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 647 GSK shares in Q1 2024, an estimated $24K.
- Focused Wealth Management first reported a position in GSK in Q3 2013 and held it in 30 quarters.
- Focused Wealth Management's GSK position peaked at $1.01M in Q3 2023.
- 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.